Resources

Cold chain maintenance workshop report: PATH, along with JSI, Village Reach, and CHAI, supported a workshop for over 50 cold chain technicians from six countries to gather and share best practices, engage in peer-to-peer learning, and explore ways to use data for improved cold chain maintenance and decision-making. The workshop report and results from a six-month follow-up survey can be found below.

PATH’s Living Labs Initiative uses human-centered design (HCD) to co-create sustainable health solutions in partnership with the intended users. Organizations that are interested in deeply engaging with health workers, communities, and other public health stakeholders to design and test innovations that increase health system capacity and advance health equity will find information below on how to partner with Living Labs to accelerate and creatively address their priorities. We offer a range of service models and partnerships, and this playbook outlines those options.

PATH and CEPI hosted a webinar on May 22, 2025, as a forum for researchers to present current work on biobanking for pandemic response, strengthen existing and new collaborations, and share experiences and lessons learned with the broader research community. Presentations included:An Introduction to the Coalition for Epidemic Preparedness Innovations (CEPI) Biospecimen Sourcing Initiative (Selorm Avumegah, CEPI)CEPI Perspectives on the Pandemic Agreement (Austin Liu, CEPI)Perspective on the Development of Respectful Partnerships and Aligning Stakeholder Goals With the Overall Aims of Biobanks (Daniel Simeon-Dubach, MedService)Strategies for Rapid Deployability in Biobanking: International Agency for Research on Cancer’s Experiences in Implementing Rapid Collection Initiatives (Zisis Kozlakidis, International Agency for Research on Cancers/World Health Organization)Access and Sharing Regional-Representative Characterized Specimens in a Federated and Distributed Biorepository System: The Need for Data Harmonization Across Sites and Standard Protocols (May Chu and Thomas Jaenisch, Colorado School of Public Health)

This report provides data and information on the current and projected global autodisable (AD) syringe market. It includes a PATH forecast of AD syringe demand from 2025 through 2028, which estimates a need for nearly 2 billion AD syringes in 2025 and relatively small fluctuations in global demand through 2028. Additionally, the report includes information about current market events (such as recent outbreaks), innovations (such as microarray patches), and key stakeholder interests that may impact the AD syringe market in the near future.

Improving maternal and child health is a foundational investment in long-term health and prosperity. It shapes life outcomes from birth through adulthood through safer pregnancy and deliveries, proper nutrition, and protection from deadly childhood diseases. These interventions are not only lifesaving; they are among the most cost-effective investments a government can make.As the US government seeks to redesign its approach to foreign aid, PATH’s Center for Advocacy and Policy has published a white paper identifying five key recommendations to ensure future investments can continue saving the lives of moms and kids around the world while aligning with American interests and values.